Drop in ED visits, admissions seen in hospitals targeted by ransomware
May 30, 2024
A transient decrease was seen, with a return to preattack levels within eight weeks; an increase was seen in emergency department visits at nearby hospitals.
Listeria risk prompts recall of Planters peanut products
May 07, 2024
To date, no reports of illnesses have been linked to the recalled products have been reported.
Candy company recalls products due to salmonella risk
May 08, 2024
A Midwestern candy company has issued a massive recall due to the risk of salmonella tainting some of its products.
FDA approves new antibiotic for uncomplicated urinary tract tnfections
Apr 30, 2024
Approval of Pivya is for female adults with UTIs caused by susceptible isolates of E. coli, P. mirabilis,and S. saprophyticus.
Few cancer survivors fully adherent to ACS nutrition and physical activity guidelines
Apr 23, 2024
Factors associated with greater adherence include female sex, older age, Black race and higher educational level.
Use of CT angiogram on the rise for headache, dizziness in emergency department
Apr 17, 2024
There was a 67.4% increase in head and neck computed tomography angiography ordering for emergency department patients from 2017 to 2021.
AACR: Little benefit seen for cancer drugs given accelerated approval
Apr 08, 2024
Fewer than half of the cancer drugs granted accelerated approval demonstrate clinical benefit.
One in seven drug supply chain issue reports tied to drug shortages
Apr 10, 2024
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic.
FDA approves new antibiotic for three indications
Apr 08, 2024
Zevtera is approved for S. aureus bloodstream infections, acute bacterial skin/skin structure infections and bacterial pneumonia.
FDA approves first prescription digital therapy for major depression
Apr 04, 2024
The adjunctive treatment, delivered via smartphone app, reduces depression symptoms in participants on antidepressant medication.